SPLITOAK STRATEGIES LLC

Lobbying for CSL BEHRING LLC · Biotherapeutics company providing recombinant, plasma-derived and cell and gene products.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Pennsylvania · House · Senate · $40,000.00 income · posted Jan 20, 2026

Bills named in this filing 2

Lobbying activity 2

Medicare/Medicaid

H.R.1476/S.694, PLASMA Act

Health Issues

Issues related to plasma-derived therapies in rare diseases and critical care settings

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.